Evidence map›Paper›PMID 23436818›Full record

Trial reportArthritis care & research2013

Choosing wisely: the American College of Rheumatology's Top 5 list of things physicians and patients should question.

Jinoos Yazdany, Gabriela Schmajuk, Mark Robbins, David Daikh, Ashley Beall, Edward Yelin, Jennifer Barton, Adam Carlson, Mary Margaretten, Joann Zell and 5 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Arthritis care & research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Autoantibody Ordering Patterns Across a Tertiary Hospital: A Retrospective Audit.Open access rheumatology : research and reviews · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Jinoos YazdanyDivision of Rheumatology, University of California, San Francisco, Box 0920, San Francisco, CA 94143-0920, USA. jinoos.yazdany@ucsf.edu
Gabriela Schmajuk
Mark Robbins
David Daikh
Ashley Beall
Edward Yelin
Jennifer Barton
Adam Carlson
Mary Margaretten
Joann Zell
Lianne S Gensler
Victoria Kelly
Kenneth Saag
Charles King
American College of Rheumatology Core Membership Group

Funding

Clinical and Transtional Science InstituteKL2TR000143 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$11.9M
Evaluating Health Care Quality in Systemic Lupus ErythematosusK23AR060259 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI YAZDANY, JINOOS · 2011 to 2015
$638k
NCATS NIH HHS KL2 TR000143NIAMS NIH HHS K23 AR060259NIAMS NIH HHS K23-AR060259
6 · The paper itself

Abstract

objectiveWe sought to develop a list of 5 tests, treatments, or services commonly used in rheumatology practice whose necessity or value should be questioned and discussed by physicians and patients.

methodsWe used a multistage process combining consensus methodology and literature reviews to arrive at the American College of Rheumatology's (ACR) Top 5 list. Rheumatologists from diverse practice settings generated items using the Delphi method. Items with high content agreement and perceived high prevalence advanced to a survey of ACR members, who comprise >90% of the US rheumatology workforce. To increase the response rate, a nested random sample of 390 rheumatologists received more intensive survey followup. The samples were combined and weighting procedures were applied to ensure generalizability. Items with high ratings underwent literature review. Final items were then selected and formulated by the task force.

resultsOne hundred five unique items were proposed and narrowed down to 22 items during the Delphi rounds. A total of 1,052 rheumatologists (17% of those contacted) participated in the member-wide survey, whereas 33% of those in the nested random sample participated; respondent characteristics were similar in both samples. Based on survey results and available scientific evidence, 5 items (relating to antinuclear antibodies, Lyme disease, magnetic resonance imaging, bone absorptiometry, and biologic therapy for rheumatoid arthritis) were selected for inclusion.

conclusionThe ACR Top 5 list is intended to promote discussions between physicians and patients about health care practices in rheumatology whose use should be questioned and to assist rheumatologists in providing high-value care.

Indexed as

Choice BehaviorPatient ParticipationAntirheumatic AgentsArthritis, RheumatoidBiological ProductsDelphi TechniqueDiagnostic Tests, RoutineFollow-Up StudiesHealth SurveysHumansLyme DiseaseMagnetic Resonance ImagingPhysiciansPractice Guidelines as TopicRheumatologyUnited StatesAntirheumatic AgentsBiological Products

Identifiers

PMID23436818
PMCPMC4106486

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.